Rheumatology treats musculoskeletal and autoimmune diseases, including arthritis, lupus, gout, and vasculitis.
Send us all your questions or requests, and our expert team will assist you.
The hallmark presentation of Sjögren’s syndrome is often referred to as the “sicca complex,” derived from the Latin word for dry. However, this term simplifies what a profound physiological failure of the mucous membranes. Xerophthalmia, or dry eye, is not merely a sensation of dryness; it is a breakdown of the tear film that protects the cornea. Patients describe a gritty, burning sensation, often feeling as though there is sand in their eyes. The lack of tears leads to friction between the eyelid and the globe, resulting in microabrasions on the corneal surface. Over time, this chronic irritation can lead to photophobia (light sensitivity), blurred vision, and in severe cases, corneal ulceration and scarring, which can threaten sight.
Xerostomia, or dry mouth, is equally debilitating. Saliva is a critical biological fluid containing enzymes for digestion, antibodies for immune defense, and minerals for remineralizing teeth. In Sjögren’s patients, saliva flow is drastically reduced or ceases entirely. This leads to a multitude of secondary conditions.
The regenerative perspective sees these symptoms as the result of glandular apoptosis (cell death). The severity of the sicca symptoms often correlates with the degree of lymphocytic infiltration seen on biopsy. However, there is sometimes a disconnect where patients report severe dryness despite having some residual glandular flow, suggesting that the inflammation may also affect the neural signaling that tells the glands to function. Addressing this neuro-secretory disconnect is a nuanced aspect of modern symptom management.
Beyond dryness, fatigue is the most common and often the most disabling symptom reported by patients. This is not normal tiredness that resolves with sleep; it is a profound, debilitating exhaustion usually described as “flu-like.” It impacts cognitive function, leading to “brain fog,” memory lapses, and difficulty concentrating. The biological basis of this fatigue is linked to elevated circulating pro-inflammatory cytokines, such as interleukin-1 and tumor necrosis factor. The body is in a constant state of high metabolic demand as it fights the internal autoimmune battle.
Musculoskeletal pain is another frequent complaint, affecting a significant majority of patients.
Regenerative medicine views these systemic symptoms as evidence of the widespread inflammatory burden. Therapies that target the immune system systemically, such as intravenous stem cell infusions, are often evaluated by their ability to reduce these constitutional symptoms. Improvement in fatigue and pain scores is a key metric of success in clinical trials, recognizing that quality of life is determined by more than tear production
Sjögren’s syndrome can aggressively target the nervous system. Peripheral neuropathy is a well-documented complication characterized by numbness, tingling, or burning sensations in the hands and feet. This is caused by inflammation of the small blood vessels that supply the nerves (vasculitis) or by a direct autoimmune attack on the nerve fibers. In some cases, the autonomic nervous system is affected, leading to dysautonomia. This can result in abnormalities in heart rate regulation, blood pressure control, and gastrointestinal motility, further complicating the clinical picture.
Pulmonary involvement is another serious consideration. The same dryness that affects the mouth can affect the airways, leading to a dry, chronic cough (xerotrachea). More seriously, the inflammation can extend into the lung tissue, leading to interstitial lung disease (ILD). This involves scarring and inflammation of the tissue between the air sacs, leading to shortness of breath and reduced oxygen transfer.
The presence of these extraglandular conditions classifies the patient as having “high systemic activity.” These scenarios often trigger a more aggressive treatment approach. From a regenerative standpoint, stem cells’ potential to reduce fibrosis (scarring) makes them an attractive option for managing complications such as interstitial lung disease, where traditional anti-inflammatories may have limited efficacy in reversing established damage
Although less common, renal (kidney) involvement is a critical aspect of the disease spectrum. The most frequent renal manifestation is tubulointerstitial nephritis. This involves inflammation of the kidney tubules and the surrounding tissue. It can lead to renal tubular acidosis, a condition in which the kidneys fail to properly acidify the urine, resulting in electrolyte imbalances (low potassium), potentially kidney stones, and compromised kidney function. Glomerulonephritis, which affects the filtering units of the kidney, can also occur, particularly in patients with mixed cryoglobulinemia.
Vascular involvement, specifically vasculitis, represents one of the most severe forms of the disease. It manifests as inflammation of the blood vessels, which can restrict blood flow to tissues.
Patients with vasculitis or renal involvement require vigilant monitoring. These conditions are markers of severe B-cell hyperactivity. The presence of cryoglobulins (abnormal proteins in the blood that clump in the cold) is a strong risk factor for these complications and also for the development of lymphoma. Managing these conditions requires a comprehensive strategy that addresses the underlying autoimmunity, often necessitating the most potent immunomodulatory therapies available in the modern pharmacopeia.
The cumulative burden of these symptoms creates a significant psychological and social impact. The disease’s invisible nature often leads to misunderstandings among family, friends, and colleagues. A patient may look perfectly healthy while suffering from exhausting fatigue and chronic pain. This discrepancy can lead to isolation and depression. The constant need to manage dryness using eye drops every hour, sipping water constantly, and avoiding specific environments can make social interactions and professional duties challenging.
Sleep disruption is chronic. Patients typically wake up multiple times per night due to dry mouth (requiring drinking) or dry eyes (requiring ointment). This fragmented sleep perpetuates the cycle of fatigue and pain. Sexual dysfunction is another under-discussed but prevalent issue, particularly in women, due to vaginal dryness (dyspareunia), which is a direct mucosal manifestation of the syndrome.
Holistic care acknowledges these impacts. Mental health support, sleep hygiene counseling, and open communication about intimate health are integral parts of the management plan. Validating the patient’s experience is the first step in effective treatment. By addressing the “total load” of the disease, clinicians can help patients navigate the complex challenges of living with Sjögren’s syndrome.
Liv Hospital Ulus
Spec. MD. Yıldız Gonca Doğru
Physiotheraphy and Rehabilitation
Liv Hospital Vadistanbul
Spec. MD. Muhsin Doran
Physiotheraphy and Rehabilitation
Liv Hospital Bahçeşehir
Prof. MD. Nazife Berna Tander
Physiotheraphy
Liv Hospital Bahçeşehir
Spec. MD. Gürkan Yılmaz
Rheumatology
Liv Hospital Bahçeşehir
Spec. MD. Roya Soltanalizadeh
Physiotheraphy
Liv Hospital Bahçeşehir
Spec. MD. Sibel Ertürkler
Physiotheraphy
Liv Hospital Topkapı
Spec. MD. Nevzat Koca
Rheumatology
Liv Hospital Topkapı
Spec. MD. Orge Fatoş Demirtaş
Physiotheraphy and Rehabilitation
Liv Hospital Topkapı
Spec. MD. Turgay Demiray
Physiotheraphy and Rehabilitation
Liv Hospital Ankara
Assoc. Prof. MD. Ali Erhan Özdemirel
Rheumatology (Physical Therapy)
Liv Hospital Ankara
Prof. MD. Haşim Çakırbay
Physiotheraphy and Rehabilitation
Liv Hospital Ankara
Spec. MD. Beril Özturan
Physiotheraphy and Rehabilitation
Liv Hospital Gaziantep
Spec. MD. Kasım Osmanoğlu
Physiotheraphy
Liv Hospital Gaziantep
Spec. MD. Başak Öğüt Perktaş
Physiotheraphy
Liv Hospital Gaziantep
Spec. MD. Hasan Kılıç
Rheumatology
Liv Hospital Samsun
Prof. MD. Mehmet Sayarlıoğlu
Rheumatology
Liv Bona Dea Hospital Bakü
MD. ŞAİQ MAHMUDOV
Physiotheraphy
Liv Bona Dea Hospital Bakü
Spec. MD. VEFA QULİYEVA
Pediatric Rheumatology
Liv Bona Dea Hospital Bakü
Spec. MD. Nümuna Aliyeva
Rheumatology
Liv Bona Dea Hospital Bakü
Spec. MD. ZÖHRE HAŞIMOVA
Physiotheraphy
Spec. MD. Şaig Mahmudov
Physiotheraphy and Rehabilitation
Liv Hospital Ulus + Liv Hospital Bahçeşehir
Prof. MD. Şenol Kobak
Rheumatology
Send us all your questions or requests, and our expert team will assist you.
While general dry eye can be caused by aging or screen use, Sjögren’s-related dry eye (Keratoconjunctivitis Sicca) is caused by an autoimmune attack that destroys the lacrimal glands. It is typically more severe, chronic, and accompanied by inflammation. The tears produced are often of poor quality, lacking the necessary oils and mucins to coat the eye, which can lead to potential corneal damage if untreated.
Yes, significantly. Saliva protects teeth by neutralizing acids and remineralizing enamel. In Sjögren’s syndrome, the lack of saliva leaves teeth vulnerable to rapid and severe decay (cavities), often starting at the gum line. Patients are also at higher risk for gum disease and oral yeast infections (thrush), making rigorous dental care essential.
Yes, Sjögren’s can affect both the peripheral and central nervous systems. Peripheral neuropathy is common, causing numbness, tingling, or burning pain in the hands and feet. Less commonly, it can affect the central nervous system, leading to cognitive dysfunction (brain fog), headaches, or issues mimicking multiple sclerosis. It can also affect the autonomic nervous system, regulating blood pressure and heart rate.
“Brain fog” describes the cognitive difficulties experienced by many patients, including trouble concentrating, memory lapses, and slower mental processing. It is not just tiredness; it is a cognitive impairment linked to the systemic inflammation and fatigue associated with the disease. It can vary in intensity from day to day and significantly impact work and daily activities.
While both conditions cause joint pain and stiffness, Sjögren’s arthritis is typically “non-erosive.” This means that while the joints are painful and swollen, the inflammation usually does not eat away at the bone or cause the deformities seen in severe Rheumatoid Arthritis. However, the pain can still be significant and interfere with daily function, often requiring similar anti-inflammatory treatments
BlogRheumatologyApr 28, 2026We explain still syndrome, a rare disease with fever, arthritis, and rash. Get expert diagnosis and compass...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 26 75